Subscribe to Newsletter

Drug Discovery

Business & Regulation Standards & Regulation

Another Year of Innovation

| Stephanie Vine

A video tour of the top FDA approvals from 2023

Discovery & Development Drug Discovery

Pharma’s Portal to the Lab of the Future

| Becky Upton | 4 min read

Labs of the future will use VR, AR, AI and more. But we must overcome the barriers of implementation, including cultural resistance.

Discovery & Development Drug Discovery

Release the Beast

| Pandora Pound | 5 min read

The FDA Modernization Act opens the door for more innovative alternatives to animal testing for drug discovery and development

Discovery & Development Drug Discovery

Addressing Epilepsy

| Stefanie Dedeurwaerdere | 4 min read

The challenges of complex disorders require collaboration, embracing technological developments, and acknowledging the gaps in access to medicine

Discovery & Development Drug Delivery

At First Sight

| Jamie Irvine | 13 min read

Three companies – Cardinal Health, REGENXBIO, and Beacon Therapeutics – help us explore gene therapy development in the ophthalmic space

Discovery & Development Drug Discovery

Humans and Machines: Exploring the Reaches of Chemical Space

| Ryan Walsh, Ying Zhang | 6 min read

Machine learning has significant promise, but we should never overlook the importance of the human factor.

Discovery & Development Drug Delivery

MIA and Potent Plants

| Jamie Irvine | 2 min read

Can genetically engineering yeast be used to produce safe and scalable schizophrenia plant-inspired drugs?

Business & Regulation Profession

Interviews To Inspire

| Jamie Irvine

Our roundup of some of our thoughtful and inspiring video interviews and roundtables from the past year.

Discovery & Development Drug Delivery

Bringing a New MOA to the Table

| Jamie Irvine | 3 min read

Cerevel Therapeutics' Emraclidine - in development for schizophrenia and Alzheimer’s disease psychosis - yields positive results in phase Ib trial

Discovery & Development Drug Delivery

Artificial Future

| Jamie Irvine | 3 min read

Exploring the potential of hybrid peptide-DNA nanostructures and artificial life

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register